QIAGEN Operating Margin 2006-2021 | QGEN

Current and historical operating margin for QIAGEN (QGEN) over the last 10 years. The current operating profit margin for QIAGEN as of September 30, 2021 is 26.90%.
QIAGEN Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2021-09-30 $2.24B $0.61B 27.37%
2021-06-30 $2.19B $0.53B 24.03%
2021-03-31 $2.07B $0.48B 23.44%
2020-12-31 $1.87B $0.39B 20.70%
2020-09-30 $1.71B $0.31B 18.17%
2020-06-30 $1.61B $0.06B 3.66%
2020-03-31 $1.55B $0.00B 0.00%
2019-12-31 $1.53B $-0.03B -1.70%
2019-09-30 $1.52B $-0.02B -1.19%
2019-06-30 $1.51B $0.27B 17.59%
2019-03-31 $1.51B $0.26B 17.19%
2018-12-31 $1.50B $0.27B 17.71%
2018-09-30 $1.50B $0.22B 14.77%
2018-06-30 $1.48B $0.21B 14.04%
2018-03-31 $1.45B $0.18B 12.17%
2017-12-31 $1.42B $0.15B 10.79%
2017-09-30 $1.39B $0.11B 8.21%
2017-06-30 $1.36B $0.10B 7.19%
2017-03-31 $1.35B $0.11B 7.86%
2016-12-31 $1.34B $0.10B 7.40%
2016-09-30 $1.32B $0.15B 11.59%
2016-06-30 $1.30B $0.15B 11.65%
2016-03-31 $1.28B $0.16B 12.57%
2015-12-31 $1.28B $0.18B 13.97%
2015-09-30 $1.29B $0.14B 10.99%
2015-06-30 $1.31B $0.15B 11.12%
2015-03-31 $1.33B $0.15B 11.62%
2014-12-31 $1.34B $0.16B 11.98%
2014-09-30 $1.35B $0.17B 12.94%
2014-06-30 $1.33B $0.16B 11.87%
2014-03-31 $1.32B $0.08B 5.78%
2013-12-31 $1.30B $0.06B 4.84%
2013-09-30 $1.29B $0.08B 6.06%
2013-06-30 $1.27B $0.08B 6.54%
2013-03-31 $1.26B $0.16B 12.84%
2012-12-31 $1.25B $0.17B 13.48%
2012-09-30 $1.24B $0.10B 8.06%
2012-06-30 $1.23B $0.10B 7.75%
2012-03-31 $1.20B $0.10B 7.99%
2011-12-31 $1.17B $0.10B 8.38%
2011-09-30 $1.12B $0.17B 15.08%
2011-06-30 $1.11B $0.19B 16.73%
2011-03-31 $1.09B $0.18B 16.74%
2010-12-31 $1.09B $0.19B 17.39%
2010-09-30 $1.09B $0.17B 15.87%
2010-06-30 $1.08B $0.18B 16.36%
2010-03-31 $1.05B $0.18B 17.47%
2009-12-31 $1.01B $0.18B 17.82%
2009-09-30 $0.96B $0.15B 15.45%
2009-06-30 $0.93B $0.15B 15.82%
2009-03-31 $0.91B $0.14B 15.66%
2008-12-31 $0.89B $0.15B 16.46%
2008-09-30 $0.87B $0.19B 21.36%
2008-06-30 $0.81B $0.16B 19.95%
2008-03-31 $0.73B $0.15B 20.30%
2007-12-31 $0.65B $0.13B 20.31%
2007-09-30 $0.57B $0.22B 38.34%
2007-06-30 $0.51B $0.22B 42.60%
2007-03-31 $0.49B $0.30B 61.24%
2006-12-31 $0.47B $0.38B 80.69%
2006-09-30 $0.44B $0.28B 62.16%
2006-06-30 $0.43B $0.27B 64.47%
2006-03-31 $0.41B $0.19B 44.90%
2005-12-31 $0.40B $0.10B 24.37%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $10.791B $1.870B
Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $141.747B 8.96
Bio-Rad Laboratories (BIO.B) United States $17.038B 34.58
Biohaven Pharmaceutical Holding (BHVN) United States $7.896B 0.00
Emergent Biosolutions (EBS) United States $2.380B 8.56
Arcus Biosciences (RCUS) United States $2.057B 0.00
Myovant Sciences (MYOV) United Kingdom $1.157B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.011B 0.00
Zymeworks (ZYME) Canada $0.386B 0.00
Ambrx Biopharma (AMAM) United States $0.188B 0.00
SQZ Biotechnologies (SQZ) United States $0.178B 0.00
Enzo Biochem (ENZ) United States $0.154B 19.88